The Journal of Pediatrics
Volume 140, Issue 2 , Pages 205-209 , February 2002

Lung tissue concentrations of nicotine in sudden infant death syndrome (SIDS)

Received 25 April 2001 ,Revised 16 November 2001 ,Accepted 28 November 2001.

References 

  1. Haglund B, Cnattingius S. Cigarette smoking as a risk factor for sudden infant death syndrome: a population-based study. Am J Public Health. 1990;80:29–32
  2. Mitchell EA, Scragg R, Stewart AW, Becroft DM, Taylor BJ, Ford RP, et al.  Results from the first year of the New Zealand cot death study. N Z Med J. 1991;104:71–76
  3. Rintahaka PJ, Hirvonen J. The epidemiology of sudden infant death syndrome in Finland in 1969-1980. Forensic Sci Int. 1986;30:219–233
  4. Taylor JA, Sanderson M. A re-examination of the risk factors for the sudden infant death syndrome. J Pediatr. 1995;126:887–891
  5. Klonoff-Cohen HS, Edelstein SL, Lefkowitz ES, Srinivasan IP, Kaegi D, Chang JC, et al.  The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. JAMA. 1995;273:795–798
  6. Murphy J, Newcombe R, Sibert J. The epidemiology of sudden infant death syndrome. J Epidemiol Community Health. 1982;36:17–21
  7. Naeye R, Ladis B, Drage J. SIDS: a prospective study. Arch Pediatr Adolesc Med. 1976;130:1207–1210
  8. Steele R, Langworth J. The relationship of antenatal and postnatal factors to sudden unexpected death in infancy. Can Med Assoc J. 1966;94:1165–1172
  9. Malloy M, Hoffman H, Peterson D. Sudden infant death syndrome and maternal smoking. Am J Public Health. 1992;82:1380–1382
  10. Peterson D. The SIDS reassessment of growth retardation in relation to maternal smoking and the hypoxia hypothesis. Am J Epidemiol. 1981;113:583–589
  11. Bergman A, Wiesner L. Relationship of passive cigarette smoking to sudden infant death syndrome. Pediatrics. 1976;58:665–668
  12. McGlashan N. Sudden infant deaths in Tasmania: 1980-86. Soc Sci Med. 1989;29:1015–1026
  13. Avery M, Frantz I. To breathe or not to breathe: what we learned about apneic spells and SIDS. N Engl J Med. 1983;309:107–108
  14. Milerad J, Rajs J, Gilund E. Nicotine and cotinine levels in pericardial fluid in victims of SIDS. Acta Paediatr Scand. 1994;83:59–62
  15. Milerad J, Vege A, Opdal S, Rognum TO. Objective measurements of nicotine exposure in victims of sudden infant death syndrome and in other unexpected child deaths. J Pediatr. 1998;133:232–236
  16. US Department of Health and Human Services . The health consequences of involuntary smoking: a report of the surgeon general. Washington (DC): : US Government Printing Office; 1986;
  17. Steyn K, Yach D, Stander I, Fourie JM. Smoking in urban pregnant women in South Africa. S Afr Med J. 1997;87:460–463
  18. Urakawa N, Nagata T, Kudo K, Kimura K, Imamura T. Simultaneous determination of nicotine and cotinine in various human tissues using capillary gas chromatography/mass spectrometry. Int J Legal Med. 1994;106:232–236
  19. Willinger M, James LS, Catz C. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel by the National Institute of Child Health and Human Development. Pediatr Pathol. 1991;11:677–684
  20. Langone J, Gjika HB, Van Vunakis H. Nicotine and its metabolites: radioimmunoassay for nicotine and cotinine. Biochemistry. 1973;12:5015–5030
  21. Kyerematen GA, Vessel ES. Metabolism of nicotine. Drug Metab Rev. 1991;23:3–41
  22. Pilotti A. Biosynthesis and mammalian metabolism of nicotine. Acta Physiol Scand Suppl. 1980;479:13–17
  23. Feldman Y, Koren G, Mattice D, Shear NH, Pellegrini E, MacLeod SM. Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. Teratology. 1989;40:37–46
  24. Domino EF, Hornbach E, Demana T. The nicotine content of common vegetables. N Engl J Med. 1993;329:437
  25. Eliopoulos C, Klein J, Phan MK, Knie B, Greenwald M, Chitayat D, et al.  Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA. 1994;271:621–623
  26. Ludden TM, Schanker LS, Lanman RC. Binding of organic compounds to rat liver and lung. Drug Metab Dispos. 1976;4:8–16
  27. Benowitz NL. Clinical pharmacology of inhaled drugs of abuse: implications in understanding nicotine dependence. NIDA Research Monograph Series. 1990;99:12–29

☆ Supported in part by the Brain and Tissue Bank for Developmental Disorders (NICHHD contract N01-HD8-3283), and the Canadian Institutes for Health Research. Dr McMartin was supported by a studentship of the Canadian Foundation for the Study of Infant Deaths.

☆☆ Dr Koren is a Senior Scientist of the Canadian Institutes for Health Research and holder of the Duchemay and Canadian Foundation for Women's Health Chair in Better Pharmacotherapy During Pregnancy and Lactation.

★ †Deceased.

★★ Reprint requests: Gideon Koren, MD, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1X8.

PII: S0022-3476(02)56804-9

doi: 10.1067/mpd.2002.121937

The Journal of Pediatrics
Volume 140, Issue 2 , Pages 205-209 , February 2002

Article Tools